172 related articles for article (PubMed ID: 33016678)
1. [SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies].
Putilina MV; Grishin DV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8. Vyp. 2):58-64. PubMed ID: 33016678
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies.
Putilina MV; Grishin DV
Neurosci Behav Physiol; 2021; 51(5):577-582. PubMed ID: 34176996
[TBL] [Abstract][Full Text] [Related]
3. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and COVID-19: friends or foes?
Rokni M; Hamblin MR; Rezaei N
Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
[TBL] [Abstract][Full Text] [Related]
5. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
7. [SARS-CoV-2 infection: do not neglect neurological symptoms!].
Pouga L
Rev Prat; 2020 May; 70(5):532-536. PubMed ID: 33058643
[TBL] [Abstract][Full Text] [Related]
8. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
Serrano-Castro PJ; Estivill-Torrús G; Cabezudo-García P; Reyes-Bueno JA; Ciano Petersen N; Aguilar-Castillo MJ; Suárez-Pérez J; Jiménez-Hernández MD; Moya-Molina MÁ; Oliver-Martos B; Arrabal-Gómez C; Rodríguez de Fonseca F
Neurologia (Engl Ed); 2020 May; 35(4):245-251. PubMed ID: 32364119
[TBL] [Abstract][Full Text] [Related]
9. Does SARS-CoV-2 infection cause chronic neurological complications?
Hascup ER; Hascup KN
Geroscience; 2020 Aug; 42(4):1083-1087. PubMed ID: 32451846
[TBL] [Abstract][Full Text] [Related]
10. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
11. Neurological consequences of COVID-19: what have we learned and where do we go from here?
Jarrahi A; Ahluwalia M; Khodadadi H; da Silva Lopes Salles E; Kolhe R; Hess DC; Vale F; Kumar M; Baban B; Vaibhav K; Dhandapani KM
J Neuroinflammation; 2020 Sep; 17(1):286. PubMed ID: 32998763
[TBL] [Abstract][Full Text] [Related]
12. More on Neurologic Features in Severe SARS-CoV-2 Infection.
Sarikaya B
N Engl J Med; 2020 Jun; 382(26):e110. PubMed ID: 32453516
[No Abstract] [Full Text] [Related]
13. More on Neurologic Features in Severe SARS-CoV-2 Infection.
Larvie M; Lev MH; Hess CP
N Engl J Med; 2020 Jun; 382(26):e110. PubMed ID: 32453515
[No Abstract] [Full Text] [Related]
14. High-dose intravenous vitamin C may help in cytokine storm in severe SARS-CoV-2 infection.
de Melo AF; Homem-de-Mello M
Crit Care; 2020 Aug; 24(1):500. PubMed ID: 32792018
[No Abstract] [Full Text] [Related]
15. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.
Helms J; Kremer S; Meziani F
N Engl J Med; 2020 Jun; 382(26):e110. PubMed ID: 32453517
[No Abstract] [Full Text] [Related]
16. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
18. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
19. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi F; Tortora C; Argenziano M; Di Paola A; Punzo F
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
